Antimycin A shows selective antiproliferation to oral cancer cells by oxidative stress‐mediated apoptosis and DNA damage

The antibiotic antimycin A (AMA) is commonly used as an inhibitor for the electron transport chain but its application in anticancer studies is rare. Recently, the repurposing use of AMA in antiproliferation of several cancer cell types has been reported. However, it is rarely investigated in oral c...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental toxicology Vol. 35; no. 11; pp. 1212 - 1224
Main Authors Yu, Tzu‐Jung, Hsieh, Che‐Yu, Tang, Jen‐Yang, Lin, Li‐Ching, Huang, Hurng‐Wern, Wang, Hui‐Ru, Yeh, Yun‐Chiao, Chuang, Ya‐Ting, Ou‐Yang, Fu, Chang, Hsueh‐Wei
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.11.2020
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The antibiotic antimycin A (AMA) is commonly used as an inhibitor for the electron transport chain but its application in anticancer studies is rare. Recently, the repurposing use of AMA in antiproliferation of several cancer cell types has been reported. However, it is rarely investigated in oral cancer cells. The purpose of this study is to investigate the selective antiproliferation ability of AMA treatment on oral cancer cells. Cell viability, flow cytometry, and western blotting were applied to explore its possible anticancer mechanism in terms of both concentration‐ and exposure time‐effects. AMA shows the higher antiproliferation to two oral cancer CAL 27 and Ca9‐22 cell lines than normal oral HGF‐1 cell lines. Moreover, AMA induces the production of higher reactive oxygen species (ROS) levels and pan‐caspase activation in oral cancer CAL 27 and Ca9‐22 cells than in normal oral HGF‐1 cells, providing the possible mechanism for its selective antiproliferation effect of AMA. In addition to ROS, AMA induces mitochondrial superoxide (MitoSOX) generation and depletes mitochondrial membrane potential (MitoMP). This further supports the AMA‐induced oxidative stress changes in oral cancer CAL 27 and Ca9‐22 cells. AMA also shows high expressions of annexin V in CAL 27 and Ca9‐22 cells and cleaved forms of poly (ADP‐ribose) polymerase (PARP), caspase 9, and caspase 3 in CAL 27 cells, supporting the apoptosis‐inducing ability of AMA. Furthermore, AMA induces DNA damage (γH2AX and 8‐oxo‐2′‐deoxyguanosine [8‐oxodG]) in CAL 27 and Ca9‐22 cells. Notably, the AMA‐induced selective antiproliferation, oxidative stress, and DNA damage were partly prevented from N‐acetylcysteine (NAC) pretreatments. Taken together, AMA selectively kills oral cancer cells in an oxidative stress‐dependent mechanism involving apoptosis and DNA damage.
Bibliography:Funding information
Chimei‐KMU jointed project, Grant/Award Number: 109CM‐KMU‐007; Health and welfare surcharge of tobacco products, the Ministry of Health and Welfare, Taiwan, Republic of China, Grant/Award Number: MOHW 109‐TDU‐B‐212‐134016; Kaohsiung Medical University Research Center, Grant/Award Number: KMU‐TC108A04; Ministry of Science and Technology, Taiwan, Grant/Award Numbers: MOST 108‐2314‐B‐037‐020, MOST 108‐2314‐B‐037‐080, MOST 108‐2320‐B‐037‐015‐MY3; National Sun Yat‐sen University‐KMU Joint Research Project, Grant/Award Number: #NSYSUKMU 109‐I002; Ministry of Health and Welfare, Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital, Grant/Award Number: KMUH104‐4R20; National Sun Yat‐sen University; Ministry of Science and Technology
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1520-4081
1522-7278
1522-7278
DOI:10.1002/tox.22986